You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
億帆醫藥(002019.SZ):未來公司將繼續努力在靶點發現、化合物篩選、分子設計、藥學研究、臨牀研究等關鍵環節進行嘗試
格隆匯 02-24 16:23

格隆匯2月24日丨億帆醫藥(002019.SZ)於投資者互動平臺表示,當前在大分子藥研發領域中公司已開始做一些輔助工具設計和預測功能,化藥研發領域中在專利分析、工藝路線設計、雜質評估和藥理毒理分析等環節也有所應用。未來,公司將繼續努力在靶點發現、化合物篩選、分子設計、藥學研究、臨牀研究等關鍵環節進行嘗試,致力於通過前沿科技降低研發成本、提升研發效率。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account